[HTML][HTML] Understanding COVID-19-associated coagulopathy

EM Conway, N Mackman, RQ Warren… - Nature Reviews …, 2022 - nature.com
Abstract COVID-19-associated coagulopathy (CAC) is a life-threatening complication of
SARS-CoV-2 infection. However, the underlying cellular and molecular mechanisms driving …

Vasculopathy in COVID-19

R Flaumenhaft, K Enjyoji… - Blood, The Journal of the …, 2022 - ashpublications.org
COVID-19 is a primary respiratory illness that is frequently complicated by systemic
involvement of the vasculature. Vascular involvement leads to an array of complications …

[HTML][HTML] Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism

MA Patel, MJ Knauer, M Nicholson, M Daley… - Molecular …, 2022 - Springer
Background Long-COVID is characterized by prolonged, diffuse symptoms months after
acute COVID-19. Accurate diagnosis and targeted therapies for Long-COVID are lacking …

[HTML][HTML] The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1

CS Whyte, M Simpson, GB Morrow, CA Wallace… - Journal of Thrombosis …, 2022 - Elsevier
Background Severe COVID‐19 disease is associated with thrombotic complications and
extensive fibrin deposition. This study investigates whether the hemostatic complications in …

[HTML][HTML] Endotheliopathy in acute COVID-19 and long COVID

AG Vassiliou, CS Vrettou, C Keskinidou… - International Journal of …, 2023 - mdpi.com
The pulmonary endothelium is a highly regulated organ that performs a wide range of
functions under physiological and pathological conditions. Since endothelial dysfunction …

Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1)

GB Morrow, NJ Mutch - Seminars in thrombosis and …, 2023 - thieme-connect.com
Plasminogen activator inhibitor 1 (PAI-1), a SERPIN inhibitor, is primarily known for its
regulation of fibrinolysis. However, it is now known that this inhibitor functions and …

[HTML][HTML] The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction

S Xu, Y Liu, Y Ding, S Luo, X Zheng, X Wu… - … and Targeted Therapy, 2021 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is regarded as an endothelial disease
(endothelialitis) with its patho-mechanism being incompletely understood. Emerging …

COVID‐19‐related coagulopathy: A review of pathophysiology and pharmaceutical management

M Kohansal Vajari, M Shirin… - Cell biology …, 2021 - Wiley Online Library
December 2019 will never be forgotten in the history of medicine when an outbreak of
pneumonia of unknown etiology in Wuhan, China sooner or later prompted the World Health …

[HTML][HTML] Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and …

M Sayyadi, S Hassani, M Shams, A Dorgalaleh - Annals of Hematology, 2023 - Springer
The coagulation, fibrinolytic, anticoagulation, and complement systems are in delicate
balance with the vessel wall endothelium ensuring appropriate hemostasis. Coagulopathy …

[HTML][HTML] Meta-analysis and systematic review of coagulation disbalances in COVID-19: 41 studies and 17,601 patients

P Len, G Iskakova, Z Sautbayeva… - Frontiers in …, 2022 - frontiersin.org
Introduction Coagulation parameters are important determinants for COVID-19 infection. We
conducted meta-analysis to assess the association between early hemostatic parameters …